Clinical trials are still under way to determine if #ivermectin has any benefits against #COVID19. In the meantime, health authorities caution against using it for the #coronavirus.
With Peru’s health system overwhelmed last year, many residents began self-medicating, an indicator of things to come.
As Covid-19 cases in Peru rose rapidly during the early months of the pandemic, public interest in the drug ivermectin surged. Misleading information suggesting the drug, used to treat parasites in humans and livestock, had been proven effective against coronavirus reached many Peruvians online, doctors told the Guardian. With vaccines still in development, desperate physicians soon began administering ivermectin to patients and, despite a lack of evidence of the drug’s effectiveness in treating Covid, Peru’s government included it in treatment guidelines in early May 2020. A frenzy ensued. “We ran out of ivermectin in all the pharmacies,” recalled Dr Patricia Garcia, the country’s former health minister. “Then there was a black market, and that’s when things got even worse because the veterinary ivermectin use started.” Like several other Latin American countries, Peru in 2020 experienced a dire Covid emergency that overwhelmed its underfunded healthcare system. Many residents turned to self-medicating with ivermectin, Garcia said. Local politicians and television hosts told audiences to take the drug. Some Peruvians began taking ivermectin that was formulated for livestock and administered through injections, and images of people with necrotic tissue on their skin from shots made their way to Garcia’s desk. Evangelical groups touted ivermectin as equivalent to a vaccine, sending volunteers to inject thousands of people in indigenous communities while referring to the drug as a “salvation”.
Peru’s experience with ivermectin was an early indicator of things to come. Over the past year, the international hype over the drug has led to runs on livestock suppliers, a boom in illegal trafficking and rampant misinformation in several countries.
Read more at:
